4.7 Article

Paper biosensors for detecting elevated IL-6 levels in blood and respiratory samples from COVID-19 patients

期刊

SENSORS AND ACTUATORS B-CHEMICAL
卷 330, 期 -, 页码 -

出版社

ELSEVIER SCIENCE SA
DOI: 10.1016/j.snb.2020.129333

关键词

SARS-CoV-2; COVID-19; Paper-based; Biosensor; IL-6; Smartphone

资金

  1. FEDER/Ministerio de Ciencia, Innovacion y Universidades/Agencia Estatal de Investigacion [CTQ2017-82432-R, CTQ2017-92226-EXP]
  2. IdISBa/Impost turisme sostenible/Agencia d'Estrategia Turistica de les Illes Balears-Govern de les Illes Balears
  3. Roche (Stop fuga de cerebros program)
  4. Instituto de Salud Carlos III (Sara Borrell contract)
  5. European Social Fund (ESF) through JoTReSdOS program
  6. Instituto de Salud Carlos III [COV20/00943]
  7. Carlos III Health Institute

向作者/读者索取更多资源

Decentralizing COVID-19 care through the use of biosensors for detecting severe cases in decentralized healthcare settings allows for low limit of detection and semi-quantitative measurements of IL-6 in blood and respiratory samples. This enables stratification of COVID-19 patients based on IL-6 levels and potential adaptation for detecting other cytokines.
Decentralizing COVID-19 care reduces contagions and affords a better use of hospital resources. We introduce biosensors aimed at detecting severe cases of COVID-19 in decentralized healthcare settings. They consist of a paper immunosensor interfaced with a smartphone. The immunosensors have been designed to generate intense colorimetric signals when the sample contains ultralow concentrations of IL-6, which has been proposed as a prognosis biomarker of COVID-19. This is achieved by combining a paper-based signal amplification mechanism with polymer-filled reservoirs for dispensing antibody-decorated nanoparticles and a bespoken app for color quantification. With this design we achieved a low limit of detection (LOD) of 10(-3) pg mL(-1) and semi-quantitative measurements in a wide dynamic range between 10(-3) and 10(2) pg mL(-1) in PBS. The assay time is under 10 min. The low LOD allowed us to dilute blood samples and detect IL-6 with an LOD of 1.3 pg mL(-1) and a dynamic range up to 10(2) pg mL(-1). Following this protocol, we were able to stratify COVID-19 patients according to different blood levels of IL-6. We also report on the detection of IL-6 in respiratory samples (bronchial aspirate, BAS) from COVID-19 patients. The test could be easily adapted to detect other cytokines such as TNF-alpha and IL-8 by changing the antibodies decorating the nanoparticles accordingly. The ability of detecting cytokines in blood and respiratory samples paves the way for monitoring local inflammation in the lungs as well as systemic inflammation levels in the body.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据